Association of anosmia and Covid-19 : a systematic review / Josef Carlo AngbuTe, Jules Reinier Ramos, and Danilo D. Deveza, Jr.

Contributor(s):

Language: english Publication details: Fairview, Quezon City: Department of Otolaryngology, FEU-NRMF, 2022.Description: 26 pages: tables; (in folder) with flash drive (soft copy)Content type:

text

Media type:

unmediated

Carrier type:

volume26

Subject(s):

LOC classification:

ENT 2022 0002

Summary: Abstract: Anosmia or "loss of smell" has been reported in patients with COVID-19 since pandemic began. We conducted a systematic review of the available literatures to evaluate the global the global incidence of anosmia in patients infected with COVID-19 and assess its relationship with severity including mortality. The study aims to discuss if anosmia can be used as a prognostic symptoms for COVID-19 moreover in determining the severity of the disease. A comprehensive search of the Medline/PubMed/, Elsevier/ Embase, Web of Science, LitCovid NIH, Proquest, Cochrane Library, and WHO COVID-19 databases was done. Data on the study characteristics ( anosmia, Covid19 prognosis and severity) were extracted following the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses" (PRISMA) guidelines. Newcastle-Ottawa scale (NOS) was use to evaluate the quality of the eligible articles. Pooled prevalence for COVID-19 with anosmia were calculated. A total of 77 articles were considered with 16, 761 COVID-19 patients, anosmia was reported in 8855 patients with a pooled prevalence of 50.4% globally (95% Cl:43.0%, 57.9%). The link between the occurrence of COVID-19 and anosmia were analyzed with 3834 COVID-19 patients with anosmia and 5714 non-COVID-19 patients (mainly SARS-CoV-2-like symptoms with negative RT-PCR). Anosmia is more common in COVID-19 patients with an OR of 9.31 (95%t Cl: 8.058, 10.754) and a p value of <0.001. "Loss of smell" is common in patients infected with COVID-19 and should be added as one of the key indicators in screening the population, it has been utilized as a preventive strategy where COVID-19 patients with anosmia should begin self-isolation. This will aid in the prevention of the disease's spread. Anosmia was also Connected with a somewhat better prognosis for the course of the disease.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Call number	Status	Notes	Date due	Barcode
Room Use	Far Eastern University - Nicanor Reyes Medical Foundation Research	ENT 2022 0002 (Browse shelf(Opens below))	Available	with flash drive (soft copy)		R000675

Browsing Far Eastern University - Nicanor Reyes Medical Foundation shelves, Shelving location: Research Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	ENT 2020 0003 Extranodal NK/T cell lymphoma, nasal type in a Filipino male /	ENT 2020 0004 Superior canal dehiscence syndrome : a case report /	ENT 2022 0001 Chrondrosarcoma of the mandible in a Filipino female /	ENT 2022 0002 Association of anosmia and Covid-19 : a systematic review /	M CFM 2024 0006 The Relationship between chronotypes and the Big Five Personality Traits of medical students /	MCFM20190010 Effects of physical activity on visual and auditory reaction times, and memory retention /	MED ND 0001 Variation in body temperature assessment using ear thermo scan among doctors, nurses and attendants at FEU-NRMF Medical Center /	Next

Includes appendices and bibliographical references.

Abstract: Anosmia or "loss of smell" has been reported in patients with COVID-19 since pandemic began. We conducted a systematic review of the available literatures to evaluate the global the global incidence of anosmia in patients infected with COVID-19 and assess its relationship with severity including mortality. The study aims to discuss if anosmia can be used as a prognostic symptoms for COVID-19 moreover in determining the severity of the disease. A comprehensive search of the Medline/PubMed/, Elsevier/ Embase, Web of Science, LitCovid NIH, Proquest, Cochrane Library, and WHO COVID-19 databases was done. Data on the study characteristics ( anosmia, Covid19 prognosis and severity) were extracted following the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses" (PRISMA) guidelines. Newcastle-Ottawa scale (NOS) was use to evaluate the quality of the eligible articles. Pooled prevalence for COVID-19 with anosmia were calculated. A total of 77 articles were considered with 16, 761 COVID-19 patients, anosmia was reported in 8855 patients with a pooled prevalence of 50.4% globally (95% Cl:43.0%, 57.9%). The link between the occurrence of COVID-19 and anosmia were analyzed with 3834 COVID-19 patients with anosmia and 5714 non-COVID-19 patients (mainly SARS-CoV-2-like symptoms with negative RT-PCR). Anosmia is more common in COVID-19 patients with an OR of 9.31 (95%t Cl: 8.058, 10.754) and a p value of <0.001. "Loss of smell" is common in patients infected with COVID-19 and should be added as one of the key indicators in screening the population, it has been utilized as a preventive strategy where COVID-19 patients with anosmia should begin self-isolation. This will aid in the prevention of the disease's spread. Anosmia was also Connected with a somewhat better prognosis for the course of the disease.

Research - Department of Otolaryngology

There are no comments on this title.

to post a comment.